astemizole Hismanal withdrawn
Selected indexed studies
- Cardiovascular safety of antihistamines. (Postepy Dermatol Alergol, 2014) [PMID:25097491]
- Hay fever treatments--which should be tried first? (J R Coll Gen Pract, 1987) [PMID:2896796]
- Pharmacokinetic overview of oral second-generation H1 antihistamines. (Int J Clin Pharmacol Ther, 1998) [PMID:9629995]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Cardiovascular safety of antihistamines. (2014) pubmed
- Hay fever treatments--which should be tried first? (1987) pubmed
- Pharmacokinetic overview of oral second-generation H1 antihistamines. (1998) pubmed
- Antihistamine drug withdrawn by manufacturer. (1999) pubmed
- Modeling the Bioactivation and Subsequent Reactivity of Drugs. (2021) pubmed
- Drug compound screening in single and integrated multi-organoid body-on-a-chip systems. (2020) pubmed
- Mapping pharmaceuticals in rat brain sections using MALDI imaging mass spectrometry. (2010) pubmed
- Allosteric Modulation of Kv11.1 (hERG) Channels Protects Against Drug-Induced Ventricular Arrhythmias. (2016) pubmed
- Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis. (1992) pubmed
- QT prolongation and safety in the Indian population. (2007) pubmed